Sotera Health (NASDAQ:SHC) Receives $15.70 Consensus PT from Analysts

Shares of Sotera Health (NASDAQ:SHC) have earned an average rating of “Moderate Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $15.70.

SHC has been the subject of several analyst reports. Royal Bank of Canada restated an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a report on Tuesday, August 6th. Barclays increased their price objective on shares of Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research report on Tuesday, August 6th.

Sotera Health Stock Up 1.0 %

Shares of Sotera Health stock opened at $16.76 on Wednesday. The company has a current ratio of 2.93, a quick ratio of 2.59 and a debt-to-equity ratio of 5.46. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The company has a market cap of $4.75 billion, a P/E ratio of 88.22 and a beta of 2.07. The company’s fifty day simple moving average is $15.17 and its two-hundred day simple moving average is $12.93.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.04. The business had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The business’s revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.19 EPS. Research analysts anticipate that Sotera Health will post 0.64 EPS for the current year.

Insider Activity

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now owns 49,215,301 shares of the company’s stock, valued at $739,705,974.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 55.12% of the company’s stock.

Institutional Trading of Sotera Health

Institutional investors have recently made changes to their positions in the business. CWM LLC increased its holdings in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after acquiring an additional 993 shares during the last quarter. Point72 DIFC Ltd grew its position in shares of Sotera Health by 556.6% during the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after purchasing an additional 5,544 shares in the last quarter. Quest Partners LLC bought a new stake in shares of Sotera Health in the fourth quarter worth about $139,000. Acadian Asset Management LLC lifted its position in shares of Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after buying an additional 8,248 shares in the last quarter. Finally, Sandia Investment Management LP bought a new position in Sotera Health during the first quarter valued at approximately $120,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.